As of June 30, 2026, Wilson Bayly Holmes-Ovcon Limited carries a market capitalization of 907.47B, placing it among publicly traded companies globally. Its enterprise value stands at 514.25B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 907.47B |
| Enterprise Value | 514.25B |
Wilson Bayly Holmes-Ovcon Limited's next confirmed earnings release is scheduled for March 2, 2027.
| Earnings Date | 3/2/2027 |
As of June 30, 2026, Wilson Bayly Holmes-Ovcon Limited has 51.96M shares outstanding.
| Shares Outstanding | 51.96M |
These figures are as of June 30, 2026.
| PB Ratio | 1.50 |
| P/TBV Ratio | 1.65 |
As of June 30, 2026, Wilson Bayly Holmes-Ovcon Limited maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.17 |
| Quick Ratio | 0.44 |
| Debt / Equity | 5.16 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 6,148.00 |
As of the close on October 22, 2026, Wilson Bayly Holmes-Ovcon Limited's stock has declined approximately 5.44% over the past 52 weeks. The 50-day moving average sits at 14,271.44, while the 200-day moving average is 16,249.44.
| 52-Week Price Change | -5.44% |
| 50-Day Moving Average | 14,271.44 |
| 200-Day Moving Average | 16,249.44 |
As of June 30, 2026, Wilson Bayly Holmes-Ovcon Limited holds 447.03B in cash and equivalents against 32.29B in total debt, resulting in a net debt position of -425.20B. Total book value stands at 603.60B, with working capital of 175.70B providing operational flexibility.
| Cash & Cash Equivalents | 447.03B |
| Total Debt | 32.29B |
| Net Debt | -425.20B |
| Equity (Book Value) | 603.60B |
| Book Value Per Share | 11,617.47 |
| Working Capital | 175.70B |
Already premium?